Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human PLD1 and PLD2). Halopemid is an antagonist of dopamine receptors. Halopemid can be used in psychotropic research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 50.00 | |
5 mg | In stock | $ 128.00 | |
10 mg | In stock | $ 213.00 | |
25 mg | In stock | $ 428.00 | |
50 mg | In stock | $ 639.00 | |
100 mg | In stock | $ 890.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 143.00 |
Description | Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human PLD1 and PLD2). Halopemid is an antagonist of dopamine receptors. Halopemid can be used in psychotropic research. |
Targets&IC50 | PLD1:220 nM, PLD2:310 nM |
In vitro | In transdifferentiated MOVAS cells, Halopemide (1-2 μM; 21 days) influences calcification[1]. |
In vivo | In the majority of monkeys tested, Halopemide (10 mg/kg; p.o.) causes dyskinesias[2]. |
Molecular Weight | 416.88 |
Formula | C21H22ClFN4O2 |
CAS No. | 59831-65-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (131.93 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Halopemide 59831-65-1 GPCR/G Protein Metabolism Neuroscience Others Dopamine Receptor Phospholipase inhibit psychotropic calcification MOVAS Inhibitor cells dyskinesias cancer inhibitor